⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15187041 | 0.93 | MEN1 (0.77) | — | |
| SCHEMBL22171101 | 0.92 | MEN1 (0.61) | — | |
| SCHEMBL22171099 | 0.92 | MEN1 (0.61) | — | |
| SCHEMBL25887714 | 0.91 | MEN1 (0.74) | — | |
| SCHEMBL15856109 | 0.91 | MEN1 (0.74) | — | |
| SCHEMBL14608401 | 0.91 | MEN1 (0.74) | — | |
| SCHEMBL25885490 | 0.91 | MEN1 (0.74) | — | |
| SCHEMBL7478566 | 0.91 | MEN1 (0.74) | — | |
| SCHEMBL22203854 | 0.90 | MEN1 (0.65) | — | |
| Ammonia Solution, Strong SCHEMBL9256322 | 0.89 | MEN1 (0.71) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110845415-A | Environment-friendly synthesis method of 2-ethyl-4-methylimidazole | 广州市固研电子材料有限公司 | 2020-02-28 | — | — | CN | claimed |
| EP-1064253-B1 | ANTI-TUMOUR AGENTS | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | claimed |
| US-6346633-B1 | TERT-AMINOPHENYLESTER OF ACID | ASTRAZENECA AB (SE) | 2002-02-12 | — | — | US | claimed |
| EP-1064253-A1 | ANTI-TUMOUR AGENTS | AstraZeneca AB (SE) | 2001-01-03 | — | — | EP | claimed |
| WO-1999048857-A1 | ANTI-TUMOUR AGENTS | ASTRAZENECA AB (SE) | 1999-09-30 | — | — | WO | claimed |
| US-4775755-A | DIAMINOPROPANE OR TETRAHYDROPYRIMIDINE REACTED WITH FORMAMIDE | STAMICARBON B. V. (NL) | 1988-10-04 | — | — | US | claimed |
| US-20250188110-A1 | SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2025-06-12 | — | — | US | disclosed |
| WO-2024094645-A1 | NONSTICK POLYMER COATINGS FOR SHORT-TERM IMPLANTS | Universität Siegen (DE) | 2024-05-10 | — | — | WO | disclosed |
| US-11779560-B2 | Methods of using nitric oxide donor compounds for treatment of COVID-19 and other infectious diseases | COEURATIVE, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11753403-B2 | EIF4E inhibitors and uses thereof | PIC Therapeutics, Inc. (US) | 2023-09-12 | — | — | US | disclosed |
| WO-2023017152-A1 | SPECIFIC SMALL MOLECULE INHIBITORS THAT BLOCK KMT9 METHYLTRANSFERASE ACTIVITY AND FUNCTION | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2023-02-16 | — | — | WO | disclosed |
| CN-110845415-B | Environment-friendly synthesis method of 2-ethyl-4-methylimidazole | 广东固研电子材料有限公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-110845415-B | Environment-friendly synthesis method of 2-ethyl-4-methylimidazole | 广东固研电子材料有限公司 | 2022-12-16 | — | — | CN | disclosed |
| EP-2253611-A1 | Low molecular weight quaternary ammonium salt dispersants | Xerox Corporation (US) | 2010-11-24 | — | — | EP | disclosed |
| US-7417164-B2 | Fluorescent dyes for use in glucose sensing | GLUMETRICS INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-20080027245-A1 | FLUORESCENT DYES FOR USE IN GLUCOSE SENSING | GLUMETRICS INC. (US) | 2008-01-31 | — | — | US | disclosed |
| EP-1064253-B1 | ANTI-TUMOUR AGENTS | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | disclosed |
| US-6346633-B1 | TERT-AMINOPHENYLESTER OF ACID | ASTRAZENECA AB (SE) | 2002-02-12 | — | — | US | disclosed |
| EP-1064253-A1 | ANTI-TUMOUR AGENTS | AstraZeneca AB (SE) | 2001-01-03 | — | — | EP | disclosed |
| WO-1999048857-A1 | ANTI-TUMOUR AGENTS | ASTRAZENECA AB (SE) | 1999-09-30 | — | — | WO | disclosed |